Metabolic Syndrome and Non-alcoholic Fatty Pancreas Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F25%3A00082121" target="_blank" >RIV/65269705:_____/25:00082121 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/25:00142421 RIV/61988987:17110/25:A2603DJS

Výsledek na webu

<a href="https://link.springer.com/article/10.1007/s44411-025-00173-x" target="_blank" >https://link.springer.com/article/10.1007/s44411-025-00173-x</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s44411-025-00173-x" target="_blank" >10.1007/s44411-025-00173-x</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Metabolic Syndrome and Non-alcoholic Fatty Pancreas Disease

Popis výsledku v původním jazyce

The prevalence of overweight and obesity has been increasing worldwide over the past decade. In 2022, according to WHO data, 43% of individuals globally were classified as overweight or obese. Considering that obesity is associated with a range of serious diseases, such as type 2 diabetes mellitus, cardiovascular and neurovascular diseases, malignancies, and steatosis of parenchymal organs like the liver and pancreas, obesity and overweight represent significant health and societal challenges. The presence of abdominal-type obesity, hyperglycemia, elevated serum triglyceride levels, low HDL cholesterol levels, and arterial hypertension characterizes a condition known as metabolic syndrome. The presence of fat in the pancreatic parenchyma is a hallmark of non-alcoholic fatty pancreas disease (NAFPD). This condition may contribute to the development of exocrine pancreatic insufficiency, diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), or pancreatic carcinoma. Since the localization of pancreatic fat is most prominent in the head of the pancreas, and because the most common site of pancreatic carcinoma is in the same region of the gland, the association between pancreatic steatosis and pancreatic carcinoma is more than likely. For this reason, patients with pancreatic steatosis require continuous medical monitoring.

Název v anglickém jazyce

Metabolic Syndrome and Non-alcoholic Fatty Pancreas Disease

Popis výsledku anglicky

The prevalence of overweight and obesity has been increasing worldwide over the past decade. In 2022, according to WHO data, 43% of individuals globally were classified as overweight or obese. Considering that obesity is associated with a range of serious diseases, such as type 2 diabetes mellitus, cardiovascular and neurovascular diseases, malignancies, and steatosis of parenchymal organs like the liver and pancreas, obesity and overweight represent significant health and societal challenges. The presence of abdominal-type obesity, hyperglycemia, elevated serum triglyceride levels, low HDL cholesterol levels, and arterial hypertension characterizes a condition known as metabolic syndrome. The presence of fat in the pancreatic parenchyma is a hallmark of non-alcoholic fatty pancreas disease (NAFPD). This condition may contribute to the development of exocrine pancreatic insufficiency, diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), or pancreatic carcinoma. Since the localization of pancreatic fat is most prominent in the head of the pancreas, and because the most common site of pancreatic carcinoma is in the same region of the gland, the association between pancreatic steatosis and pancreatic carcinoma is more than likely. For this reason, patients with pancreatic steatosis require continuous medical monitoring.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30218 - General and internal medicine

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Bratislava Medical Journal-Bratislavske Lekarske Listy

ISSN

0006-9248

e-ISSN

1336-0345

Svazek periodika

126

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

SK - Slovenská republika

Počet stran výsledku

6

Strana od-do

1190-1195

Kód UT WoS článku

001494823600001

EID výsledku v databázi Scopus

2-s2.0-105006641579